Resources related

Resources related to Biomarker and Molecular Imaging

In this work the authors develop black phosphorus magnetic microbubbles (MBBPM) for contrast enhanced ultrasound and therapeutic imaging.
Read more
February 2021: Molecular Magnetic Resonance Imaging of Alpha v-beta-3 Integrin Expression in Tumors
Read more
Here the authors report on the synthesis, characterization, and potential utility of ultra-small NaYF4:Nd3+/NaGdF4 nanocrystals coated with manganese dioxide (usNP-MnO2) for spatiotemporal modulation of hypoxia in head and neck squamous cell carcinomas.
Read more
This is a recording for a LIVE webinar presented by Shazia Bano, PhD, Research Fellow from the Wellman Center for Photomedicine, Harvard Medical School Massachusetts General Hospital.
Read more
This recent study by Zlitni, A. et al tested a Maltotriose-based probes for fluorescence and photoacoustic imaging of bacterial infections.
Read more
This video Featured Publication highlights non-linear contrast imaging capabilities of the Vevo 3100.
Read more
Presented by Dr. Yosra Toumia, Research Fellow in the Department of Chemical Science and Technologies-University of Rome Tor Vergata.
Read more
Presented by Jesse Jokerst, PhD, Assistant Professor in the Department of NanoEngineering at University of California San Diego.
Read more
Tatjana Opacic shares a study where her lab developed a new method called motion model ultrasound localization microscopy (mULM) for morphological and functional characterization of tumors at super-resolution.
Read more
In this talk, recorded during the Innovation in Imaging Summit 2018 in Toronto, researcher Danielle Charron shares her lab's approach to creating photoacoustic nanoparticles. She highlights how a lot of the work they do in fluorescent imaging can also be done using photoacoustics as well.
Read more
This study by Yosra Toumia et al. advances the knowledge of the behavior of a hybrid system consisting of pristine graphene anchored polyvinyl alcohol microbubbles (G/PVA MB), and is a proof concept for their efficiency as contrast agents in photoacoustic as well as ultrasound imaging.
Read more
Presented by: Dr. Sandra Meyer, Senior Applications Specialist at Fujifilm VisualSonics.
Read more
Presented by: Jonathan Lavaud from Plateforme OPTIMAL, Institute for Advanced Bioscience
Read more
In this Issue: Image contest, Micromarker Giveaway and 3 reasons to attend AHA plus a whole lot more.
Read more
Metastasis rather than primary tumors determine prognosis and mortality in the majority of cancer patients. Detection of metastatic lesions is critical to determine prognosis and suitable treatments. We developed a method... Read full story.
Read more
The recent 2016 FDA approval of Bracco’s Lumason for its use in liver lesion detection for both adults and children, marks a milestone for microbubble imaging, paving the way for increased adoption and expanded clinical use of microbubbles in abdominal and pelvic imaging.
Read more
This article by Wilson, et al. uses PA contrast agent with an antibody specific to breast cancer cells to perform in vivo molecular imaging in an orthotopic mouse model of breast cancer.
Read more
Converting nanoparticles or monomeric compounds into larger supramolecular structures by endogenous or external stimuli is increasingly popular because these materials are useful for imaging and treating diseases. However, conversion of microstructures to nanostructures is less common. Read more.
Read more
Take a look at the NEW Vevo LAZR-X Photoacoustic Imaging System (featured at WMIC - World Molecular Imaging Congress in September). Presented by Drew Heinmiller, Product Manager, Fujifilm VisualSonics. 
Read more
Presented by Andrew Heinmiller, Product Manager - Photoacoustics, FUJIFILM VisualSonics Inc. In this webinar, learn about visualizing and quantifying molecular markers with photoacoustics.
Read more
The merging of drug therapy and diagnostics to advance personalized medicine is one definition of theranostics. Research in advanced theranostics elevates this concept by merging nanotechnology to benefit drug discovery. Read more.
Read more